The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Hepatic resection versus radiofrequency ablation for very early stage hepatocellular carcinoma: A Markov model analysis†
Open accessAbstract
UNLABELLED: No adequate randomized trials have been reported for a comparison between hepatic resection (HR) versus radiofrequency ablation (RFA) for the treatment of patients with very early stage hepatocellular carcinoma (HCC), defined as an asymptomatic solitary HCC <2 cm. For compensated cirrhotic patients with very early stage HCC, a Markov model was created to simulate a randomized trial between HR (group I) versus primary percutaneous RFA followed by HR for cases of initial local failure (group II) versus percutaneous RFA monotherapy (group III); each arm was allocated with a hypothetical cohort of 10,000 patients. The primary endpoint was overall survival. The estimates of the variables were extracted from published articles after a systematic review. In the parameter estimations, we assumed the best scenario for HR and the worst scenario for RFA. The mean expected survival was 7.577 years, 7.564 years, and 7.356 years for group I, group II, and group III, respectively. One-way sensitivity analysis demonstrated that group II was the preferred strategy if the perioperative mortality rate was greater than 1.0%, if the probability of local recurrence following an initial complete ablation was <1.9% or if the positive microscopic resection margin rate was >0.3%. The 95% confidence intervals for the difference in overall survival were -0.18-0.18 years between group I and II, 0.06-0.36 years between group I and III, and 0.13-0.30 years between group II and III, respectively. CONCLUSION: Primary percutaneous RFA followed by HR for cases of initial local failure was nearly identical to HR for the overall survival of compensated cirrhotic patients with very early stage HCC.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Management of Hepatocellular Carcinoma *
Bruix, J., & Sherman, M. (2005) · Hepatology · doi:10.1002/hep.20933 · Cited by 5,857
Llovet, J. M., & Bruix, J. (2003) · Hepatology · doi:10.1053/jhep.2003.50047 · Cited by 3,029
Llovet, J. M., Fuster, J., & Bruix, J. (1999) · Hepatology · doi:10.1002/hep.510300629 · Cited by 1,708
Chen, M.-S., Li, J.-Q., Zheng, Y., Guo, R.-P., Liang, H.-H., Zhang, Y.-Q., Lin, X.-J., & Lau, W. Y. (2006) · Annals of Surgery · doi:10.1097/01.sla.0000201480.65519.b8 · Cited by 1,432
Livraghi, T., Meloni, F., Di Stasi, M., Rolle, E., Solbiati, L., Tinelli, C., & Rossi, S. (2008) · Hepatology · doi:10.1002/hep.21933 · Cited by 1,103
An Analysis of 412 Cases of Hepatocellular Carcinoma at a Western Center
Fong, Y., Sun, R. L., Jarnagin, W., & Blumgart, L. H. (1999) · Annals of Surgery · doi:10.1097/00000658-199906000-00005 · Cited by 796
Percutaneous radiofrequency ablation for hepatocellular carcinoma: An analysis of 1000 cases
Tateishi, R., Shiina, S., Teratani, T., Obi, S., Sato, S., Koike, Y., Fujishima, T., Yoshida, H., Kawabe, T., & Omata, M. (2005) · Cancer · doi:10.1002/cncr.20892 · Cited by 778
Llovet, J. M., Vilana, R., Brú, C., Bianchi, L., Salmeron, J. M., Boix, L., Ganau, S., Sala, M., Pagès, M., Ayuso, C., et al. (2001) · Hepatology · doi:10.1053/jhep.2001.24233 · Cited by 759
Arii, S., Yamaoka, Y., Futagawa, S., Inoue, K., Kobayashi, K., Kojiro, M., Makuuchi, M., Nakamura, Y., Okita, K., & Yamada, R. (2000) · Hepatology · doi:10.1053/jhep.2000.20456 · Cited by 725
Sangiovanni, A., Prati, G. M., Fasani, P., Ronchi, G., Romeo, R., Manini, M., Del Ninno, E., Morabito, A., & Colombo, M. (2006) · Hepatology · doi:10.1002/hep.21176 · Cited by 628
Lin, S.-M., Lin, C.-J., Lin, C.-C., Hsu, C.-W., & Chen, Y.-C. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.09.003 · Cited by 609
Lin, S.-M., Lin, C.-J., Lin, C.-C., Hsu, C.-W., & Chen, Y.-C. (2005) · Gut · doi:10.1136/gut.2004.045203 · Cited by 592
Poon, R. T.-P., Fan, S.-T., Lo, C.-M., Liu, C.-L., & Wong, J. (1999) · Annals of Surgery · doi:10.1097/00000658-199902000-00009 · Cited by 550
Ikai, I., Arii, S., Kojiro, M., Ichida, T., Makuuchi, M., Matsuyama, Y., Nakanuma, Y., Okita, K., Omata, M., Takayasu, K., et al. (2004) · Cancer · doi:10.1002/cncr.20426 · Cited by 451
A convenient approximation of life expectancy (the “DEALE”)
Beck, J. R., Kassirer, J. P., & Pauker, S. G. (1982) · The American Journal of Medicine · doi:10.1016/0002-9343(82)90786-0 · Cited by 413
Early Hepatocellular Carcinoma As An Entity With A High Rate of Surgical Cure
Takayama, T., Makuuchi, M., Hirohashi, S., Sakamoto, M., Yamamoto, J., Shimada, K., Kosuge, T., Okada, S., Takayasu, K., & Yamasaki, S. (1998) · Hepatology · doi:10.1002/hep.510280511 · Cited by 388
Eguchi, S., Kanematsu, T., Arii, S., Okazaki, M., Okita, K., Omata, M., Ikai, I., Kudo, M., Kojiro, M., Makuuchi, M., et al. (2008) · Surgery · doi:10.1016/j.surg.2007.12.003 · Cited by 368
Nakazawa, T., Kokubu, S., Shibuya, A., Ono, K., Watanabe, M., Hidaka, H., Tsuchihashi, T., & Saigenji, K. (2007) · American Journal of Roentgenology · doi:10.2214/ajr.05.2079 · Cited by 345
Komorizono, Y., Oketani, M., Sako, K., Yamasaki, N., Shibatou, T., Maeda, M., Kohara, K., Shigenobu, S., Ishibashi, K., & Arima, T. (2003) · Cancer · doi:10.1002/cncr.11168 · Cited by 336
Minagawa, M., Ikai, I., Matsuyama, Y., Yamaoka, Y., & Makuuchi, M. (2007) · Annals of Surgery · doi:10.1097/01.sla.0000254368.65878.da · Cited by 330
Experience of 1000 patients who underwent hepatectomy for small hepatocellular carcinoma
Zhou, X.-D., Tang, Z.-Y., Yang, B.-H., Lin, Z.-Y., Ma, Z.-C., Ye, S.-L., Wu, Z.-Q., Fan, J., Qin, L.-X., & Zheng, B.-H. (2001) · Cancer · doi:10.1002/1097-0142(20010415)91:8<1479::aid-cncr1155>3.0.co;2-0 · Cited by 302
Sala, M., Fuster, J., Llovet, J. M., Navasa, M., Solé, M., Varela, M., Pons, F., Rimola, A., García-Valdecasas, J. C., Brú, C., et al. (2004) · Liver Transplantation · doi:10.1002/lt.20202 · Cited by 297
Livraghi, T., Bolondi, L., Buscarini, L., Cottone, M., Mazziotti, A., Morabito, A., & Torzilli, G. (1995) · Journal of Hepatology · doi:10.1016/0168-8278(95)80445-5 · Cited by 278
Hong, S. N., Lee, S.-Y., Choi, M. S., Lee, J. H., Koh, K. C., Paik, S. W., Yoo, B. C., Rhee, J. C., Choi, D., Lim, H. K., et al. (2005) · Journal of Clinical Gastroenterology · doi:10.1097/01.mcg.0000152746.72149.31 · Cited by 222
Lu, M., Kuang, M., Liang, L., et al. (2006) · PubMed · Cited by 200
Preoperative Predictors of Survival After Resection of Small Hepatocellular Carcinomas
Wayne, J. D., Lauwers, G. Y., Ikai, I., Doherty, D. A., Belghiti, J., Yamaoka, Y., Regimbeau, J.-M., Nagorney, D. M., Do, K.-A., Ellis, L. M., et al. (2002) · Annals of Surgery · doi:10.1097/00000658-200205000-00015 · Cited by 189
Risk of tumour seeding after percutaneous radiofrequency ablation for hepatocellular carcinoma
Livraghi, T., Lazzaroni, S., Meloni, F., & Solbiati, L. (2005) · British Journal of Surgery · doi:10.1002/bjs.4986 · Cited by 185
Elias, D. M., de Baère, T., Smayra, T., Ouellet, J. F., Roche, A., & Lasser, P. (2002) · British journal of surgery · doi:10.1046/j.1365-2168.2002.02081.x · Cited by 180
Bruno, S., Zuin, M. G., Crosignani, A. L., Rossi, S., Zadra, F., Roffi, L., Borzio, M., Redaelli, A. E., Chiesa, A., Silini, E. M., et al. (2009) · The American Journal of Gastroenterology · doi:10.1038/ajg.2009.31 · Cited by 166
Bell, B. P., Manos, M. M., Zaman, A., Terrault, N. A., Thomas, A. R., Navarro, V. J., Dhotre, K. B., Murphy, R. C., Ness, G. V., Stabach, N., et al. (2008) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2008.02071.x · Cited by 139
Ryu, M., Shimamura, Y., Kinoshita, T., Konishi, M., Kawano, N., Iwasaki, M., Furuse, J., Yoshino, M., Moriyama, N., & Sugita, M. (1997) · Japanese Journal of Clinical Oncology · doi:10.1093/jjco/27.4.251 · Cited by 121
Longterm prognosis after hepatic resection for small hepatocellular carcinoma1
Shimozawa, N., & Hanazaki, K. (2004) · Journal of the American College of Surgeons · doi:10.1016/j.jamcollsurg.2003.10.017 · Cited by 117
Uncertainty in Decision Models Analyzing Cost-Effectiveness
Hunink, M. G. M., Bult, J. R., de Vries, J. A., & Weinstein, M. C. (1998) · Medical Decision Making · doi:10.1177/0272989x9801800312 · Cited by 111
Hilal, M. A., Primrose, J. M., Casaril, A., et al. (2008) · Journal of Gastrointestinal Surgery · doi:10.1007/s11605-008-0553-4 · Cited by 110
Farinati, F., Sergio, A., Baldan, A., Giacomin, A., Nolfo, M. A. D., Poggio, P. D., Benvegnù, L., Rapaccini, G., Zoli, M., Borzio, F., et al. (2009) · BMC Cancer · doi:10.1186/1471-2407-9-33 · Cited by 96
The Half-Cycle Correction Explained: Two Alternative Pedagogical Approaches
Naimark, D. M. J., Bott, M., & Krahn, M. D. (2008) · Medical Decision Making · doi:10.1177/0272989x08315241 · Cited by 95
Molinari, M., & Helton, S. W. (2009) · The American Journal of Surgery · doi:10.1016/j.amjsurg.2009.01.016 · Cited by 76
Cited by
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
Galle, P. R., Forner, A., Llovet, J. M., Mazzaferro, V., Piscaglia, F., Raoul, J.-L., Schirmacher, P., & Vilgrain, V. (2018) · Journal of Hepatology · doi:10.1016/j.jhep.2018.03.019 · Cited by 11,406
BCLC strategy for prognosis prediction and treatment recommendation: the 2022 update
Reig, M., Forner, A., Rimola, J., Ferrer-Fàbrega, J., Burrel, M., Garcia-Criado, Á., Kelley, R. K., Galle, P. R., Mazzaferro, V., Salem, R., et al. (2022) · Journal of Hepatology · doi:10.1016/j.jhep.2021.11.018 · Cited by 4,319
Evidence-Based Diagnosis, Staging, and Treatment of Patients With Hepatocellular Carcinoma
Bruix, J., Reig, M., & Sherman, M. (2016) · Gastroenterology · doi:10.1053/j.gastro.2015.12.041 · Cited by 1,694
Hepatocellular carcinoma: clinical frontiers and perspectives
Bruix, J., Gores, G. J., & Mazzaferro, V. (2014) · Gut · doi:10.1136/gutjnl-2013-306627 · Cited by 1,364
Locoregional therapies in the era of molecular and immune treatments for hepatocellular carcinoma
Llovet, J. M., De Baere, T., Kulik, L., Haber, P. K., Greten, T. F., Meyer, T., & Lencioni, R. (2021) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-020-00395-0 · Cited by 1,044
Metadata
- Authors
- Cho, Y. K., Kim, J. K., Kim, W. T., & Chung, J. W.
- Venue
- Hepatology
- Published
- 2010-04
- Volume
- 51
- Issue
- 4
- Pages
- 1284-1290
- ISSN
- 0270-9139 (ISSN-L)
- OpenAlex
- W2041084326
- Cited by
- 276
- References
- 37
- FWCI
- 8.06
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.